SECO 2022 in review: findings presented in New Orleans

Article

SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.

The Southeastern Congress of Optometry (SECO) conference was held in New Orleans, Louisiana from March 9-13, 2022 at the Ernest N. Morial Convention Center, with a virtual platform available to online attendees.



Glaucoma

Glaucoma: More pressures than meet the eye

Other factors, besides IOP, can contribute to glaucomatous optic nerve damage

Interventional glaucoma management: The art and science

Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.

Co-managing glaucoma in 2022: The OD/MD angle

Mitch Ibach, OD, FAAO and Michael Greenwood, MD review their SECO 2022 presentation on comanaging glaucoma



Retina

Retina news: What's hot (and not)

Mohammad Rafieetary, OD, FAAO, offers a sneak peek at the latest (and fake!) news in retina.

Significance of imaging in retinal disease scans

Mohammad Rafieetary, OD, FAAO, shares highlights from his SECO 2022 presentation titled "Image-in that! Scanning for retinal disease."



Dry eye

Adding intense pulsed light to your practice

Selina McGee, OD, FAAO, disscusses her SECO 2022 presentation "See the light! Adding IPL to your practice."

Combatting dry eye during contact lens wear

Tools and therapies for dry eye with contact lens wear

The ocular surface and makeup: What you need to know

Pamela Theriot OD, FAAO, on highlights from her SECO 2022 presentation "Makeup and the ocular surface: what you need to know"



Optometry

Managing myopia with orthokeratology

Kelly Voltz, OD, FAAO, FSLS, on highlights from her presentation "Ortho-K" during the 2022 SECO meeting.

Amblyopia management: A new paradigm

Robert Sanet, OD, explains the new paradigm in amblyopia, or lazy eye, management

Focusing on giant cell arteritis and optic neuritis

Clinical pearls on giant cell arteritis (GCA) and optic neuritis

Focus on amblyopia, thyroid eye disease, and papilledema

Clinical pearls on amblyopia, thyroid eye disease, and papilledema treatments from SECO 2022.


ASCO, Johnson & Johnson Vision partner for more diversity in optometry

The unique partnership and corresponding sponsorship is the largest in ASCO’s history.

Augmenting corneal thickness with FDA-approved hypotonic riboflavin

Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.

Effective treatments for presbyopia, myopia, demodex

Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly

Recent Videos
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
EnVision Summit cofounder and program chair Dr Bonnie Henderson chats about collaborative eye care
Bonnie An Henderson in an interview for the EnVision Summit
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
© 2025 MJH Life Sciences

All rights reserved.